The U.S. Food and Drug Administration issued draft guidance for drugmakers and medical device makers to improve diversity in clinical trials, emphasizing the importance of actions to support more equitable access to medical innovations.
Judge rules in favor of AHA, declaring HHS's online tracking restrictions unlawful, impacting hospitals' use of web technologies for health information sharing.
New clinical trials presented at the American Diabetes Association's Scientific Sessions show that survodutide has promising results for reducing HbA1c levels and improving insulin sensitivity, with additional favorable changes in glucose-related biomarkers.
A community-engaged intervention aimed at reducing opioid overdose deaths did not demonstrate a statistically significant impact. The HEALing Communities Study Consortium conducted a trial spanning January 2020 to June 2022, coinciding with the COVID-19 pandemic and an increase in fentanyl-related overdoses.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
The FDA has expanded the approval of Sarepta Therapeutics' gene therapy, Elevidys, for Duchenne muscular dystrophy in patients aged four and older, addressing both ambulatory and non-ambulatory cases.
Cyberattack on Ascension hospitals across the U.S. compromises patient care, leading to medication errors, delayed lab results, and patient safety risks, as health workers struggle without access to critical electronic systems.
A recent study reveals that surgeons are most frequently reported for unprofessional behavior by coworkers, while pediatric-focused physicians are least likely to be reported.